H.M. Zarour

Type de document

Articles (6)

Co-auteur

Date

Source

Mot-clé

Patients (6) Melanoma (6) Patients (6) Blockades (4) Antigenic determinants (4) T cells (4) Human beings (4) Expression (4) Blockade (4) thérapie (3) maladie (3) Treatment (3) Inhibitors (3) Therapeutics (3) Drama (3) Antigens (3) Utilization (3) maladie (3) membrane (2) pont (2) Naples (2) Congresses (2) Apoptosis (2) Tumors (2) Theater (2) Meetings (2) Management (2) Immunotherapy (2) Immunoglobulins (2) Farm produce (2)

Documents écrit par H.M. Zarour (6) | parle de H.M. Zarour (0)

The Great Debate at "Melanoma Bridge", Naples, December 7th, 2019.
P.A. Ascierto et al. (16 avr. 2020)
Future perspectives in melanoma research: meeting report from the "Melanoma Bridge";: Napoli, December 3rd-6th 2014.
P.A. Ascierto et al. (2015)
PD-1 and Tim-3 regulate the expansion of tumor antigen-specific CD8⁺ T cells induced by melanoma vaccines.
J. Fourcade et al. (2014)
CD8(+) T cells specific for tumor antigens can be rendered dysfunctional by the tumor microenvironment through upregulation of the inhibitory receptors BTLA and PD-1.
J. Fourcade et al. (2012)
Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients.
J. Fourcade et al. (2010)
PD-1 is a regulator of NY-ESO-1-specific CD8+ T cell expansion in melanoma patients.
J. Fourcade et al. (2009)